FFM
JAZZ icon

Forum Financial Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Forum Financial Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,603
Closed -$443K – 668
2025
Q4 		$443K Hold
2,603
– – 0.01% 542
2025
Q3 		$343K Buy
2,603
+203
+8% +$24.3K ﹤0.01% 663
2025
Q2 		$255K Buy
2,400
+172
+8% +$18.7K ﹤0.01% 766
2025
Q1 		$277K Buy
2,228
+236
+12% +$30.8K ﹤0.01% 638
2024
Q4 		$245K Buy
+1,992
New +$235K ﹤0.01% 739
2022
Q3 		– Sell
-1,692
Closed -$264K – 572
2022
Q2 		$264K Buy
+1,692
New +$260K 0.01% 405

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Forum Financial Management's JAZZ Position: Q1 2026 in Review

Forum Financial Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 2,603 shares — an estimated $443K sold.

Forum Financial Management first reported a position in JAZZ in Q2 2022 and held it in 6 quarters. The position peaked at $443K in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Forum Financial Management reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 2,603 Jazz Pharmaceuticals shares in Q1 2026, an estimated $443K.
  • Forum Financial Management first reported a position in Jazz Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • Forum Financial Management's Jazz Pharmaceuticals position peaked at $443K in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.